Recent Updates
Recently added Catalysts

stannous fluoride

Phase 3

Dentin Sensitivity | Small molecule | Other |GSK plc|Last Updated: May 25, 2017

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment242
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02832375Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal HypersensitivityPHASE3 COMPLETED 242Mar 1, 2016May 12, 2016May 25, 20171 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Change From Baseline in Schiff Sensitivity Score on Day 3
Baseline, Day 3

Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.

Secondary Endpoints
Change From Baseline in Schiff Sensitivity Score After Single Use
Baseline, after single use (after 5 minutes)
Change From Baseline in Tactile Threshold Immediately After Single Use and on Day 3
Baseline, after single use (after 5 minutes) and on Day 3
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Experimental: stannous fluorideEXPERIMENTALParticipants will be instructed to dose a dry toothbrush containing 0.454% w/w of stannous fluoride (1000 parts per million \[ppm\] fluoride) with a full strip (1 inch) of toothpaste. Participants will then brush each of the two selected sensitive test teeth first followed by the whole mouth thoroughly for at least 1 minute.
Standard: sodium monofluorophosphateACTIVE_COMPARATORParticipants will be instructed to dose a dry toothbrush containing 0.76% w/w sodium monofluorophosphate (1000ppm fluoride) with a full strip (1 inch) of toothpaste. Participants will then brush each of the two selected sensitive test teeth first followed by the whole mouth thoroughly for at least 1 minute.
Interventions
NameTypeDescription
stannous fluorideDRUG0.454% w/w stannous fluoride containing 1100ppm of fluoride
sodium monofluorophosphateDRUG0.76% w/w sodium monofluorophosphate containing 1000ppm fluoride
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 65 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. * Aged 18-65 years inclusive * Understands and is willing, able and likely to comply...

Countries:United States
Unlock Eligibility Criteria